BAT drags on Reinet. The investment group says it continues to take comfort in the tobacco giant's
underlying financial results despite a slide in its share price this year.
British American Tobacco has had a torrid time of late, which reflects in its
share price. So Reinet, which counts BAT as the largest part of its investment
portfolio and net asset value (NAV), has felt the aftershock.
Releasing interims results on Friday, the investment group reported a 5.6%
decline in its NAV to "4.8 billion for the six months to end-September, from
"5.13 billion in March. That's as BAT's shares declined to 35.85, from 41.31
six months earlier, valuing Reinet's stake at "2.74 billion. Following the
slide in BAT's share price, it now makes up 56.6% of Reinet's NAV from 62.4%
in September.
BAT's share price tumbled 11.3% to a four-year low on the JSE last Monday,
with news that the US may ban menthol cigarettes in a move that could affect
as much as a quarter of its profit.
The tobacco industry is currently impacted by the US Food and Drug
Administration's continued regulation efforts and the transformation
strategies of industry players seeking to enhance their new generation
products," the company said. "Reinet continues to take comfort from the
underlying financial results, strong dividends and future prospects of BAT,
including the investment in Reynolds American Inc., decreased US tax rates and
increased focus on next-generation products."
The slide in BAT's share price this year was cushioned by an increase in the
value of some of its other investments, as well as dividends. The value of its
holding in specialist UK insurer Pension Insurance Corporation rose by 9% to
"1.43 billion, while its investment on private equity and related partnerships
declined by 1.1% to "728 million, and its holding in Trilantic Capital
Partners various funds increased by 7.8% to "194 million. It received
dividends of "37 million from BAT for the period and paid its down dividends
of some "35 million or "0.18 per share.
Commitments totalling "107 million in respect of new and existing investments
were made, and a total of "146 million funded during the period.
Its shares closed 6.7% lower at 206.19 rand on Friday, taking its losses for the
year to 24.8%. BAT has declined 41.3% year to date.
End of week 16Nov18. FTSE/JSE Allshare Top5 oversold/overbought according to
14day $RSI indicator as follow:
Omnia 12
Rebosis 14
Reinet 21
BATS 21
Richemont 27
Altron A 80 (had some legs recently)
Datatec 71
Implats 71
Metair 70
Distell 67
Top5 last week as well
-- Schalk Louw (@SchalkLouw) November 17, 2018